GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » NP Life Sciences Health Industry Group Inc (OTCPK:NPLS) » Definitions » Cash Ratio

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Cash Ratio : 1.87 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is NP Life Sciences Health Industry Group Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. NP Life Sciences Health Industry Group's Cash Ratio for the quarter that ended in Dec. 2023 was 1.87.

NP Life Sciences Health Industry Group has a Cash Ratio of 1.87. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for NP Life Sciences Health Industry Group's Cash Ratio or its related term are showing as below:

NPLS' s Cash Ratio Range Over the Past 10 Years
Min: 1.13   Med: 4.9   Max: 16.2
Current: 1.87

During the past 6 years, NP Life Sciences Health Industry Group's highest Cash Ratio was 16.20. The lowest was 1.13. And the median was 4.90.

NPLS's Cash Ratio is ranked better than
81.61% of 261 companies
in the Education industry
Industry Median: 0.7 vs NPLS: 1.87

NP Life Sciences Health Industry Group Cash Ratio Historical Data

The historical data trend for NP Life Sciences Health Industry Group's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NP Life Sciences Health Industry Group Cash Ratio Chart

NP Life Sciences Health Industry Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial 16.20 7.93 - 1.13 1.87

NP Life Sciences Health Industry Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 1.15 1.62 1.33 1.87

Competitive Comparison of NP Life Sciences Health Industry Group's Cash Ratio

For the Education & Training Services subindustry, NP Life Sciences Health Industry Group's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NP Life Sciences Health Industry Group's Cash Ratio Distribution in the Education Industry

For the Education industry and Consumer Defensive sector, NP Life Sciences Health Industry Group's Cash Ratio distribution charts can be found below:

* The bar in red indicates where NP Life Sciences Health Industry Group's Cash Ratio falls into.



NP Life Sciences Health Industry Group Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

NP Life Sciences Health Industry Group's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.071/0.038
=1.87

NP Life Sciences Health Industry Group's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.071/0.038
=1.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NP Life Sciences Health Industry Group  (OTCPK:NPLS) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


NP Life Sciences Health Industry Group Cash Ratio Related Terms

Thank you for viewing the detailed overview of NP Life Sciences Health Industry Group's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Business Description

Traded in Other Exchanges
N/A
Address
4125 Blackhawk Plaza Circle, Suite 166, Danville, CA, USA, 94506
NP Life Sciences Health Industry Group Inc offers international study tours, online and offline, in classical Chinese studies through classes, lectures, cultural, and artistic events. Its revenues are comprised of providing promotions and consulting services to its partner who gives international study tour services, commission to be received from partner enrollment services and mental health consulting services.
Executives
Guidong Wang director, 10 percent owner, officer: Chairman, CEO. Pres, Treas 4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Huaying Zhu director, officer: Secretary 4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Jonathan Ginsberg director 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Sanjun Kuang director, officer: CEO, President and Treasurer 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Meisang Hu director, 10 percent owner 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Huawei Li director, officer: Secretary 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Jianhua Wang 10 percent owner 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Headlines

No Headlines